Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Emergent BioSolutions Triples Its Coronavirus-Vaccine Manufacturing Contract With AstraZeneca
06:29pm, Monday, 27'th Jul 2020
Chalk up another contract to manufacture a coronavirus vaccine for Emergent BioSolutions (NYSE: EBS). Emergent BioSolutions, which is focused on bioterrorism and emergent diseases but also has a con
Coronavirus update: U.S. case tally climbs above 4.2 million after a fifth straight day of more than 1,000 new infections
02:53pm, Monday, 27'th Jul 2020
The U.S. case tally for the coronavirus illness COVID-19 rose above 4.2 million on Monday, after a fifth straight day of more than 1,000 new infections, as...
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
How NYC hospitals have become better equipped to treat COVID-19 patients
09:50pm, Wednesday, 22'nd Jul 2020
To combat the virus, researchers have been pushing innovations in testing, drugs and blood plasma and other treatments.
Emergent BioSolutions to Release Second Quarter 2020 Financial Results and Conduct Conference Call on July 30, 2020
10:30am, Thursday, 16'th Jul 2020
GAITHERSBURG, Md., July 16, 2020 -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the.
Axa Makes New Investment in Emergent Biosolutions Inc (NYSE:EBS)
06:24am, Monday, 13'th Jul 2020
Axa purchased a new position in shares of Emergent Biosolutions Inc (NYSE:EBS) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor pur
Emergent Biosolutions (EBS) Stock Sinks As Market Gains: What You Should Know
09:50pm, Friday, 10'th Jul 2020
Emergent Biosolutions (EBS) closed at $94.23 in the latest trading session, marking a -0.26% move from the prior day.
Is Emergent Biosolutions (EBS) Stock Outpacing Its Medical Peers This Year?
03:30pm, Friday, 10'th Jul 2020
Is (EBS) Outperforming Other Medical Stocks This Year?
Emergent (EBS) Stock Up Year to Date on Coronavirus Vaccine Deals
04:36pm, Thursday, 09'th Jul 2020
Emergent (EBS) inks deals with multiple companies to provide manufacturing services for helping them develop COVID-19 vaccine.
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
Emergent BioSolutions Gets Deeper Into Covid-19 Deals
03:25pm, Wednesday, 08'th Jul 2020
The midcap drugmaker said Wednesday it would collaborate with the Mount Sinai Health System to test a drug derived from blood plasma taken from recovered Covid-19 patients.
Emergent to partner with Mount Sinai for potential plasma-derived COVID-19 therapy
03:11pm, Wednesday, 08'th Jul 2020
Emergent BioSolutions Inc said on Wednesday it would jointly develop and run trials for its antibody product derived from plasma of recovered COVID-19 patients as a potential treatment with the Mount
The Mount Sinai Health System, Emergent BioSolutions (EBS), and ImmunoTek Bio Centers today announced that they will collaborate to develop, manufacture, and conduct clinical trials to evaluate Emerge
6 Stocks to Wade Through the Spike in Coronavirus Cases
12:11pm, Wednesday, 08'th Jul 2020
The current health scare drives market volatility and calls for investment in consumer staples, healthcare and IT sectors for stable returns.
Emergent's (EBS) 5-Year Deal to Back J&J's Coronavirus Vaccine
03:46pm, Tuesday, 07'th Jul 2020
Emergent BioSolutions (EBS) extends a five-year deal with J&J; to provide its CDMO services to produce the drug substance of the latter's COVID-19 vaccine candidate. Shares rise.
